Inpart is the leading global platform for science partnering. We provide comprehensive solutions to facilitate, optimize and track collaborations across industry and academia. 

In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry.   ​

The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations.   ​

Our commitment to excellence, creativity, and purpose-driven initiatives fuels our mission to connect the right partners at the right time for the purpose of bringing science to the market faster.   ​

Biotechnology

Life Sciences

Pharmaceutical

Inpart

Gilles T.

Nick Spirit

Martha Clay

Andrea W.

Atsumi Fujigasaki

Freya Damrell

Derek Olm

Joachim Eeckhout

Anis Rokbani

Sarah Issa

Patrick S.

Sandrine Chambre

Steffina Tagoreraj

Robin K.

Leadership Team

Software and Quality Assurance

Business Development Team

Customer Success

Product and Operations

Finance and Legal

Teams at Inpart